Back To TOP

LUCENTIS Co-pay Card

The LUCENTIS Co-pay Card Program may be able to help reduce the out-of-pocket costs for the medication LUCENTIS. If you have commercial or private insurance and meet other eligibility requirements, this program can help regardless of your income level.

 

Some health plans might not accept a co-pay card. Please contact your insurance provider to find out if your plan allows the use of co-pay cards.

 

To find out if you qualify for this program or to get a co-pay card, call (855) 218-5307 or click Get Started.

actemra_enroll


 

Qualified Patients

To qualify for this program, you must:

  • Be treated with LUCENTIS for
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Macular Edema following Retinal Vein Occlusion (RVO)
    • Diabetic Macular Edema (DME)
    • Diabetic Retinopathy (DR) in patients with DME
  • Have “commercial” or “private” insurance
    • You must not be covered in part or full by any state or federally funded programs, such as Medicare or Medicaid, Medigap, Medicare Advantage, Managed Medicaid, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
  • Live in the United States or Puerto Rico
  • Not be receiving help from the Genentech ® Access to Care Foundation, or GATCF, or other co-pay foundations for LUCENTIS

 


 

What does the program cover?

 

 

 
Program Benefit Up to $5000 per year of the patient's co-pay or co-insurance for LUCENTIS, regardless of income.*
Patients’ Responsibility The first $5 of their co-pay or co-insurance for LUCENTIS. The Co-Pay Card Program covers any additional out-of-pocket costs, up to $5000 per year.
 

 

* The LUCENTIS Co-pay Card Program does not cover costs for any other medication, procedure or diagnostic test.

Learn More About
Lucentis
  • LEARN about treatment with LUCENTIS
  • LEARN HOW the LUCENTIS Co-pay Card can help with the out-of-pocket costs for LUCENTIS
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.